시장보고서
상품코드
1469140

동물용 백신 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 투여 경로별, 유통 채널별, 지역별, 경쟁별(2019-2029년)

Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Route Of Administration, By Distribution Channel, By Region and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동물용 백신 시장은 2023년에 76억 8,000만 달러로 평가되며, 2029년까지의 CAGR은 8.18%로, 예측 기간 중 눈부신 성장을 달성할 것으로 예측됩니다.

백신은 안전성과 유효성을 보장하기 위해 면밀하고 엄격한 테스트 및 분석 과정을 거칩니다. 이 종합적인 시험에는 수년에 걸친 대규모 시험이 포함되며, 새로 개발된 항원의 유효성 및 채택률과 같은 요인을 평가합니다. 임상시험 후 단계에서 백신은 동물의 질병 발생 빈도를 유지하고 관리하는 데 중요한 역할을 합니다. 이는 동물의 건강을 보호할 뿐만 아니라 인간과 동물의 상호의존성을 고려할 때 인간의 건강에도 큰 영향을 미칩니다. 동물 백신의 가용성과 효능은 일반 대중이 다양한 목적으로 동물에 의존하고 있다는 것을 짐작할 수 있는 중요한 요소입니다. 가장 일반적으로 사용되는 동물 백신에는 광견병 백신, 구제역 백신, 말 인플루엔자 바이러스 백신 등이 있습니다. 이러한 백신은 자연적으로 획득한 면역력을 모방하여 전염병의 확산을 방지하는 매우 중요한 역할을 하며, 그 결과 동물과 인간 집단 모두를 잠재적인 전염병으로부터 보호하고 전반적인 웰빙을 보장합니다.

주요 시장 촉진요인

세계의 애완동물 입양의 증가

정부기관, 동물 협회, 대기업에 의한 구상

동물 질병의 유행 증가

주요 시장이 해결해야 할 과제

엄격한 규제

백신의 높은 보관 비용

주요 시장 동향

연구개발 활동의 증가

가축 생산의 증가

부문별 인사이트

제품별 인사이트

동물 유형별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별(약독생백신, 불활화 백신, 서브유닛 백신, DNA 백신, 유전자재조합 백신)
    • 동물 유형별(가축, 반려동물, 기타)
    • 투여 경로별(피하 투여, 근육내 투여, 경비투여)
    • 유통 채널별(동물병원, 동물 클리닉, 약국, 기타)
    • 지역별
    • 기업별(2023년)
  • 시장 맵

제6장 북미의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 동물 유형별
    • 투여 경로별
    • 유통 채널별
    • 국가별
  • 북미 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 동물 유형별
    • 투여 경로별
    • 유통 채널별
    • 국가별
  • 유럽 국가별 분석
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인

제8장 아시아태평양의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 동물 유형별
    • 투여 경로별
    • 유통 채널별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 동물 유형별
    • 투여 경로별
    • 유통 채널별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 동물용 백신 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 동물 유형별
    • 투여 경로별
    • 유통 채널별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 합병 매수(있는 경우)
  • 제품 출시(있는 경우)
  • 최근 동향

제13장 Porter's Five Forces 분석

  • 업계내의 경쟁
  • 신규 참여의 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제14장 경쟁 구도

  • Zoetis Inc.
  • Merck Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd.
  • ElancoAnimal Health Incorporated
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ouro Fino Saude Animal

제15장 전략적 제안

제16장 면책사항

KSA 24.05.17

Global Animal Vaccine Market was valued at USD 7.68 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.18% through 2029. Vaccines undergo a meticulous and rigorous process of testing and analysis, ensuring their safety and efficacy. This comprehensive testing includes extensive trials that span over several years, evaluating factors such as effectiveness and adoption rates of the newly developed antigen. In the post-trial stage, vaccines play a crucial role in maintaining and controlling the frequency of diseases in animals. This not only safeguards animal health but also has a significant impact on human health, considering the interdependence between humans and animals. The availability and effectiveness of animal vaccines are essential in estimating the public's reliance on animals for various purposes. Among the most commonly used animal vaccines are rabies vaccines, foot mouth disease vaccines, and equine influenza virus vaccines. These vaccines play a pivotal role in preventing the spread of infectious agents by simulating naturally acquired immunity, thus protecting both animal and human populations from potential outbreaks and ensuring overall well-being.

Key Market Drivers

Increasing Pet Adoption Globally

Increasing pet adoption globally has brought about a surge in the demand for animal vaccines, reflecting a growing awareness of responsible pet ownership and the need to safeguard the health of our furry companions. As more people open their homes to animals in need, the risk of disease transmission among pets and from pets to humans has also risen. This necessitates comprehensive vaccination programs to ensure the well-being of these beloved family members.

One of the key drivers behind the increased demand for animal vaccines is the desire to prevent the spread of contagious diseases in crowded shelters and homes. Animal shelters, in particular, house numerous animals in close proximity, making them vulnerable to outbreaks of diseases like parvovirus and kennel cough. Vaccinations provide a vital layer of protection, not only ensuring the health of the shelter's residents but also promoting their chances of finding permanent homes.

Furthermore, as pets become more integrated into our lives, there is a growing understanding of zoonotic diseases-ailments that can be transmitted between animals and humans. This realization has led pet owners to seek vaccination for their animals to mitigate the risk of diseases such as rabies, which can be transmitted from infected pets to humans. Consequently, veterinarians are witnessing an upswing in requests for vaccines to protect both the animals and their human companions. There has been a remarkable increase in animal health awareness among the general public. People are now more informed about the importance of regular veterinary care and preventive measures to ensure the well-being of their pets. This growing awareness has led to a surge in the demand for veterinary medicines, including vaccines, driving the global expansion of the animal vaccines market. In conclusion, the rise in pet ownership, coupled with the recognition of the positive impact that companion animals have on human health, has fueled the growth of the animal vaccines market worldwide. As more families embrace their pets as valued members, the demand for effective vaccines to safeguard their health continues to grow.

Initiatives by Government Agencies, Animal Associations, and Leading Players

The demand for animal vaccines has been steadily rising due to proactive initiatives by government agencies, dedicated animal associations, and leading players in the veterinary and pharmaceutical industries. These collaborative efforts are geared towards improving animal health, mitigating disease outbreaks, and ensuring the safety of both domestic and wild animals. Government agencies play a pivotal role in driving this demand. They often implement vaccination programs to control and prevent the spread of contagious diseases in livestock and wildlife populations. These programs not only protect animal populations but also support food security and public health. For example, government-backed campaigns targeting diseases like foot-and-mouth disease and avian influenza have led to a surge in the need for vaccines in the agricultural sector.

Animal associations, including animal welfare organizations and breed-specific clubs, are also making significant contributions. They educate pet owners and breeders about the importance of vaccination in preventing common diseases among companion animals. These associations often collaborate with veterinarians to offer affordable vaccination clinics, increasing accessibility for pet owners and promoting responsible pet ownership.

Leading players in the veterinary and pharmaceutical industries are continually investing in research and development to innovate and produce more effective and efficient vaccines. Their efforts not only meet the growing demand for vaccines but also drive advancements in animal healthcare, resulting in safer and more reliable products.

Increased Prevalence of Animal Disease

Some of the most prevalent diseases among livestock and companion animals are infectious and contagious illnesses. These diseases pose a significant threat to the health and well-being of animals worldwide. For instance, highly infectious diseases such as canine distemper can easily spread through the air, putting other companion animals at risk. Similarly, conditions like foot-and-mouth disease and contagious bovine pleuropneumonia can have devastating effects on livestock, causing economic losses and impacting food production. Given the high prevalence of these diseases, there is an urgent need for effective vaccines to combat them. Vaccination not only plays a crucial role in protecting the animals but also contributes to the overall financial and physical well-being of both humans and animals. By reducing the incidence and severity of these diseases, vaccines can help ensure a healthier and more sustainable livestock and companion animal industry.

As the awareness of the importance of animal vaccines continues to grow, the demand for them is projected to rise. This increasing demand reflects the recognition of the critical role vaccines play in safeguarding animal health and welfare. By addressing the rise in disease incidence among livestock and companion animals, vaccines can contribute to a safer and more resilient animal population.

Key Market Challenges

Stringent Regulatory Regulations

A drug regulatory authority (DRA) plays a crucial role in ensuring the quality, safety, and efficacy of medicinal products. They oversee the entire lifecycle of these products, from manufacturing and distribution to consumer use. With a focus on maintaining product quality throughout the supply chain, DRAs diligently monitor and certify valid commercial promotions. Their responsibilities include licensing products, inspecting and licensing manufacturers and distributors, conducting post-marketing surveillance, regulating claims made for product promotion, and authorizing clinical trials. Obtaining marketing approval for new vaccines from regulatory agencies is not only a complex process but also a costly and time-consuming endeavor. The ability of companies involved in vaccine development to obtain or maintain these regulatory approvals significantly impacts their financial standing. Hence, navigating the regulatory landscape becomes a critical factor in the success of vaccine development initiatives.

High Storage Costs for Vaccines

The growth of animal vaccine demand faces a significant hindrance in the form of high storage costs. The requirement for proper storage and handling of vaccines is essential to maintain their efficacy and safety. This includes maintaining specific temperature ranges, often referred to as the cold chain, which can be both technologically and financially challenging.

The need for specialized refrigeration equipment and infrastructure increases the cost of vaccine storage. Maintaining a consistent and controlled temperature environment is vital for preserving the potency of vaccines, especially for more delicate ones. This necessity means that veterinary clinics, animal shelters, and agricultural facilities must invest in costly refrigeration systems and backup generators to prevent temperature fluctuations, particularly in areas with unreliable power supplies. The expenses associated with monitoring and quality control measures are substantial. Continuous temperature monitoring, calibration, and regular maintenance of refrigeration units are essential to ensure vaccines remain effective. These ongoing costs can strain the budgets of animal healthcare providers and organizations, discouraging them from maintaining an adequate stock of vaccines.

Key Market Trends

Increase in The Number Of RD Activities

An increase in research and development activities aimed at designing effective, efficient, and high-quality vaccines for companion animals, such as dogs and cats, as well as farm animals, including horses, cows, and pigs, is expected to create promising opportunities for the veterinary-animal vaccines market. The launch of new products with improved efficacy and safety profiles will further contribute to the growth of this market. Moreover, significant technological advancements in the development of animal health vaccines, such as the use of novel adjuvants and delivery systems, are anticipated to drive the expansion of the veterinary-animal vaccines market during the forecast period. These advancements will enable the development of vaccines that provide superior protection against infectious diseases and promote better overall animal health.

Additionally, the increasing number of emerging markets, particularly in developing countries, presents a favorable environment for the growth of the veterinary-animal vaccines market. The rising awareness about the importance of animal health, coupled with the growing investments in veterinary infrastructure, will contribute to the increased adoption of vaccines for livestock and companion animals. Furthermore, the growing population of cattle and poultry in developing countries, along with the advancements in healthcare technology, including diagnostics and preventive care, will further accelerate the growth rate of the veterinary-animal vaccines market in the future. This is driven by the need to ensure the health and well-being of animals, which in turn has a direct impact on food security and public health. In conclusion, the veterinary-animal vaccines market is poised for significant growth due to the increasing focus on animal health, technological advancements, expanding markets, and the need for sustainable and safe food production.

Increase in Livestock Production

In livestock farming, veterinary vaccinations play a crucial role in enhancing overall productivity and ensuring the well-being of animals. Given the increasing global population, it is imperative to improve livestock production efficiency and enhance access to high-quality protein in order to meet the growing demand for food. According to the FAO High-Level Expert Forum, a projected global population of 9.1 billion people by 2050 necessitates a 70% increase in overall food production from 2005 levels. Vaccinations that safeguard animal health and bolster the supply chain are indispensable in achieving this objective. Moreover, they help reduce the reliance on antimicrobials for treating infections in both food-producing and companion animals. This is particularly important due to mounting concerns about antibiotic resistance in human and veterinary medicine, as well as the capacity of vaccinations to mitigate the proliferation of organisms that cause foodborne illnesses in humans. These factors contribute significantly to the growth potential of the market in the forecast period.

Segmental Insights

Product Insights

Based on the product, the segment of attenuated live vaccines has emerged as the dominant force in the animal vaccine market, accounting for a significant revenue share in 2023. Live attenuation stands as the oldest vaccination method employed in veterinary medicine, with ongoing trials exploring its potential for additional applications. Notably, this method is being evaluated for the development of protein subunit vaccines for swine, administered intramuscularly. These products play a pivotal role in reducing swine mortality rates and enhancing their overall lifespan amidst disease outbreaks. On the other hand, the recombinant vaccine segment exhibits remarkable growth potential throughout the forecast period. These vaccines effectively mitigate the risk of pathogenicity in animals' post-vaccination. Moreover, recombinant vaccines possess the capability to provide immunization against multiple virus strains, as they can accommodate multiple gene inserts. This unique attribute eliminates the need for adjuvants, enhances vaccine viability, and improves overall stability. Within the realm of veterinary medicine, notable recombinant vaccines include those targeting canine distemper, pseudorabies, Newcastle disease, Lyme disease, and avian influenza.

Animal Type Insights

Based on the animal type, the livestock segment emerged as the dominant force in the market, capturing the highest revenue share. This can be attributed to several factors, including the significant increase in the livestock population, the implementation of supportive government initiatives, and the unfortunate outbreak of diseases among cattle and sheep. Looking ahead, the companion segment is poised to exhibit the fastest growth rate during the forecast period. As pet ownership continues to rise and the demand for animal companionship grows, this segment is expected to flourish, presenting lucrative opportunities for market players.

Regional Insights

North America, comprising the United States and Canada, is estimated to hold the largest market share in the canine disorders industry. The increasing incidence of canine disorders, including but not limited to allergies, respiratory issues, and gastrointestinal problems, has led to a higher adoption of vaccination and preventive measures in the region. This, coupled with the rising pet population and the presence of ongoing research projects and initiatives, is expected to further boost the market in North America. The region's commitment to pet healthcare and continuous advancements in research and development contribute to its dominant position in the market. Efforts are being made to understand the root causes of various canine disorders and develop innovative treatments and therapies to improve the overall well-being of our beloved furry companions. The collaborative efforts of veterinarians, scientists, and pet owners in North America pave the way for advancements in the field of veterinary medicine, ensuring the best possible care for our four-legged friends.

Key Market Players

Zoetis Inc.

Merck Co., Inc.

Boehringer Ingelheim International GmbH

Biogenesis Bago SA

Indian Immunologicals Ltd.

Elanco Animal Health Incorporated

Phibro Animal Health Corporation

Neogen Corporation

Intas Pharmaceuticals Ltd.

Ouro Fino Saude Animal

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Vaccine Market,By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Animal Vaccine Market,By Animal Type:

  • Livestock
  • Companion
  • Others

Animal Vaccine Market,By Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal

Animal Vaccine Market,By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies Drug Stores
  • Others

Animal Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Vaccine Market.

Available Customizations:

Global Animal Vaccine marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validations
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Animal Vaccine Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 5.2.2.By Animal Type (Livestock, Companion, Others)
    • 5.2.3.By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
    • 5.2.4.By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies Drug Stores, Others)
    • 5.2.5.By Region
    • 5.2.6.By Company (2023)
  • 5.3.Market Map

6.North America Animal Vaccine Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.ByProduct
    • 6.2.2.By Animal Type
    • 6.2.3.By Route Of Administration
    • 6.2.4.By Distribution Channel
    • 6.2.5.By Country
  • 6.3.North America: Country Analysis
    • 6.3.1.United States Animal Vaccine Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product
        • 6.3.1.2.2.By Animal Type
        • 6.3.1.2.3.By Route Of Administration
        • 6.3.1.2.4.By Distribution Channel
    • 6.3.2.Canada Animal Vaccine Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product
        • 6.3.2.2.2.By Animal Type
        • 6.3.2.2.3.By Route Of Administration
        • 6.3.2.2.4.By Distribution Channel
    • 6.3.3.Mexico Animal Vaccine Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product
        • 6.3.3.2.2.By Animal Type
        • 6.3.3.2.3.By Route Of Administration
        • 6.3.3.2.4.By Distribution Channel

7.Europe Animal Vaccine Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product
    • 7.2.2.By Animal Type
    • 7.2.3.By Route Of Administration
    • 7.2.4.By Distribution Channel
    • 7.2.5.By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.Germany Animal Vaccine Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product
        • 7.3.1.2.2.By Animal Type
        • 7.3.1.2.3.By Route Of Administration
        • 7.3.1.2.4.By Distribution Channel
    • 7.3.2.United Kingdom Animal Vaccine Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product
        • 7.3.2.2.2.By Animal Type
        • 7.3.2.2.3.By Route Of Administration
        • 7.3.2.2.4.By Distribution Channel
    • 7.3.3.Italy Animal Vaccine Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecasty
        • 7.3.3.2.1.By Product
        • 7.3.3.2.2.By Animal Type
        • 7.3.3.2.3.By Route Of Administration
        • 7.3.3.2.4.By Distribution Channel
    • 7.3.4.France Animal Vaccine Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Product
        • 7.3.4.2.2.By Animal Type
        • 7.3.4.2.3.By Route Of Administration
        • 7.3.4.2.4.By Distribution Channel
    • 7.3.5.Spain Animal Vaccine Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Product
        • 7.3.5.2.2.By Animal Type
        • 7.3.5.2.3.By Route Of Administration
        • 7.3.5.2.4.By Distribution Channel

8.Asia-Pacific Animal Vaccine Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product
    • 8.2.2.By Animal Type
    • 8.2.3.By Route Of Administration
    • 8.2.4.By Distribution Channel
    • 8.2.5.By Country
  • 8.3.Asia-Pacific: Country Analysis
    • 8.3.1.China Animal Vaccine Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product
        • 8.3.1.2.2.By Animal Type
        • 8.3.1.2.3.By Route Of Administration
        • 8.3.1.2.4.By Distribution Channel
    • 8.3.2.India Animal Vaccine Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product
        • 8.3.2.2.2.By Animal Type
        • 8.3.2.2.3.By Route Of Administration
        • 8.3.2.2.4.By Distribution Channel
    • 8.3.3.Japan Animal Vaccine Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product
        • 8.3.3.2.2.By Animal Type
        • 8.3.3.2.3.By Route Of Administration
        • 8.3.3.2.4.By Distribution Channel
    • 8.3.4.South Korea Animal Vaccine Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1.By Product
        • 8.3.4.2.2.By Animal Type
        • 8.3.4.2.3.By Route Of Administration
        • 8.3.4.2.4.By Distribution Channel
    • 8.3.5.Australia Animal Vaccine Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1.By Product
        • 8.3.5.2.2.By Animal Type
        • 8.3.5.2.3.By Route Of Administration
        • 8.3.5.2.4.By Distribution Channel

9.South America Animal Vaccine Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product
    • 9.2.2.By Animal Type
    • 9.2.3.By Route Of Administration
    • 9.2.4.By Distribution Channel
    • 9.2.5.By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Animal Vaccine Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product
        • 9.3.1.2.2.By Animal Type
        • 9.3.1.2.3.By Route Of Administration
        • 9.3.1.2.4.By Distribution Channel
    • 9.3.2.Argentina Animal Vaccine Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product
        • 9.3.2.2.2.By Animal Type
        • 9.3.2.2.3.By Route Of Administration
        • 9.3.2.2.4.By Distribution Channel
    • 9.3.3.Colombia Animal Vaccine Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product
        • 9.3.3.2.2.By Animal Type
        • 9.3.3.2.3.By Route Of Administration
        • 9.3.3.2.4.By Distribution Channel

10.Middle East and Africa Animal Vaccine Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value
  • 10.2.Market Share Forecast
    • 10.2.1.By Product
    • 10.2.2.By Animal Type
    • 10.2.3.By Route Of Administration
    • 10.2.4.By Distribution Channel
    • 10.2.5.By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.South Africa Animal Vaccine Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Product
        • 10.3.1.2.2.By Animal Type
        • 10.3.1.2.3.By Route Of Administration
        • 10.3.1.2.4.By Distribution Channel
    • 10.3.2.Saudi Arabia Animal Vaccine Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Product
        • 10.3.2.2.2.By Animal Type
        • 10.3.2.2.3.By Route Of Administration
        • 10.3.2.2.4.By Distribution Channel
    • 10.3.3.UAE Animal Vaccine Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Product
        • 10.3.3.2.2.By Animal Type
        • 10.3.3.2.3.By Route Of Administration
        • 10.3.3.2.4.By Distribution Channel

11.Market Dynamics

  • 11.1.Drivers
  • 11.2.Challenges

12.Market Trends Developments

  • 12.1.Merger Acquisition (If Any)
  • 12.2.Product Launches (If Any)
  • 12.3.Recent Developments

13.Porters Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Products

14.Competitive Landscape

  • 14.1.Zoetis Inc.
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (As Reported)
    • 14.1.5.Recent Developments
    • 14.1.6.Key Personnel Details
    • 14.1.7.SWOT Analysis
  • 14.2.Merck Co., Inc.
  • 14.3.Boehringer Ingelheim International GmbH
  • 14.4.Biogenesis Bago SA
  • 14.5.Indian Immunologicals Ltd.
  • 14.6.ElancoAnimal Health Incorporated
  • 14.7.Phibro Animal Health Corporation
  • 14.8.Neogen Corporation
  • 14.9.Intas Pharmaceuticals Ltd.
  • 14.10.Ouro Fino Saude Animal

15.Strategic Recommendations

16.About Us Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제